Clinical Trial Update: Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for neoadjuvant adebrelimab plus the DOS regimen in locally advanced resectable gastric cancer. Recruitment is ongoing (sponsor: T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Gastric Cancer | Phase 2 | Status: RECRUITING